Robert T. Brooke serves as Executive at Genesis Biopharma, Inc, where they oversee executive responsibilities. Since joining the company, Robert T. Brooke has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 15, 2016 involved receiving (via award) 510,585 shares valued at $0.
Robert T. Brooke currently holds 965,585 shares of Genesis Biopharma, Inc (FGGT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert T. Brooke has been a net neutral trader of FGGT stock. They have purchased $0 and sold $0 worth of shares.
Robert T. Brooke's most recent insider trade was on Jul 15, 2016, when they sold 510,585 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 25, 2011 | GNBP | $0 | Other | 1,500,000 | $N/A | Discretionary |
| Mar 18, 2010 | FGGT | $0 | Gift | 2,000,000 | $N/A | Discretionary |
| Mar 18, 2010 | FGGT | $0 | Gift | 2,000,000 | $N/A | Discretionary |